Healthtech Startups

Origin Medical develops a real-time AI assistant for prenatal ultrasound examinations that aims to shorten exam times, standardize workflows, and reduce errors. It serves sonographers, reading physicians, health systems, and private practices to improve the quality and consistency of prenatal scans and patient care.

1 investor

Origin provides in-home pediatric speech, occupational, and physical therapy by matching families with local licensed therapists who visit the child's home, with sessions covered by insurance. It also serves as a marketplace for therapists to set their own schedules and build caseloads by choosing clients in their area.

1 investor

Origyn Medical develops minimally invasive gynecological medical devices, including hysteroscopy instruments, cervical health products, women's rehabilitation devices, and gynecological diagnostic tools such as a single-use electronic endoscope. The company serves clinicians and hospitals in the women's health field, with operations in Hangzhou and Hunan, China.

1 investor

Orion Health builds a unified healthcare platform combining digital front-end and care record systems, serving healthcare providers and systems to improve care efficiency and patient outcomes through data insights and machine learning.

1 investor

Orio Therapeutics develops protein-based therapeutics using a technology that modifies therapeutic proteins with a built-in delivery system to control their localization at the injection site, improving efficacy and reducing dosage in regenerative medicine. Its first application is a molecule to protect cardiac muscle following a heart attack (myocardial infarction) by reducing fibrosis and cellular death.

1 investor

Oroi provides virtual reality applications that deliver entertainment and cognitive stimulation for older adults, aiming to support emotional wellbeing and train cognitive functions. Used with VR headsets, its content includes 360° panoramic landscapes, cognitive training exercises, and pedal-based physical activity, and is used in care homes and home care (SAD) services.

1 investor

emeis (formerly Orpea) operates nursing homes, psychiatric and rehabilitation (SMR) clinics, and home-care services across France, providing personalized medical and social care for elderly, ill, or dependent people. It runs more than 350 establishments in France with around 30,000 staff.

1 investor

Orphalan develops and commercializes innovative therapies for patients with rare diseases, with a focus on unmet medical needs where current treatments are limited or absent. The company has successfully brought trientine tetrahydrochloride (Cuprior®/Cuvrior®) to market for Wilson disease treatment across 30+ countries.

1 investor

Ortho BioMed combines expertise in medicine, engineering, and data science to develop medical technology solutions that improve patient outcomes.

1 investor

1 investor

Orthodontic Partners is an orthodontic service organization that partners with orthodontic practices, providing administrative and business support in areas such as accounting, HR, marketing, IT, and reporting, along with a clinical advisory board and shared best practices. It serves orthodontists across the United States who want operational support while retaining focus on patient care.

1 investor

Orthofix develops medical devices and surgical solutions for orthopedic procedures, with a focus on spine surgery and limb reconstruction. The company serves physicians and patients globally and emphasizes product quality, safety, and environmental responsibility in its operations.

1 investor

OrthoLoneStar is a management services organization (MSO) that oversees and supports the operations of individual orthopedic practices. It is led by executive and divisional leadership teams.

1 investor

OrthoPediatrics is a medical device company that develops products for pediatric orthopedic surgery, trauma, and deformity correction.

1 investor

Orvida Pharma develops pharmaceuticals for rare genetic skin diseases and orphan indications, with expertise spanning drug development from early discovery through FDA and EMA regulatory approval.

1 investor

Orvue is developing a single-use, robotic camera for laparoscopy that is controlled directly by the surgeon, replacing manual scope handling with robotic positioning for greater stability. The platform is designed for surgical use and intended to capture procedural data.

1 investor

Oryx offers a tablet-based visual training program built on perceptual learning and neuroplasticity that trains the brain to process near-vision input more efficiently, aiming to reduce or eliminate dependence on reading glasses. It targets adults over 40 experiencing age-related decline in near vision and works through daily adaptive sessions delivered via an iPad or Android app.

1 investor

Oryzon is a public clinical-stage biopharmaceutical company that uses epigenetics to discover and develop personalized therapies for patients with cancer and central nervous system (CNS) disorders. Its platform identifies and validates biomarkers and therapeutic targets to translate into drug candidates such as vafidemstat and iadademstat.

1 investor

OS Therapies (OST) is a clinical-stage cancer immunotherapy company developing treatments that activate the immune system to target HER2-expressing cancers, initially focusing on osteosarcoma in children and adults. It plans to expand its lead candidate into breast, colorectal, esophageal, lung, ovarian, and pancreatic cancers and other solid tumors.

1 investor

Osang Healthcare is an in-vitro diagnostic company that develops and manufactures biochemistry, immunology, and molecular diagnostic devices for global OEM and ODM partners. The company distributes diagnostic equipment to customers across more than 100 countries and plans to expand into digital health platforms and health supplements.

1 investor

OSAZ is a science-backed beauty brand formulating tinted mineral sunscreens and lip protection products designed to match diverse skin tones without grey cast or flashback. The company uses AI and skin data to develop inclusive SPF products for consumers across different climates and skin tones.

1 investor

Oscillum develops biosensors and active packaging additives for food, pharmaceutical, and cosmetic products. Its technologies enable real-time product monitoring and extend shelf life by preserving freshness and quality.

1 investor

OSF HealthCare is an integrated health system operating 16 hospitals, urgent care clinics, primary and specialty care facilities, and digital health services across Illinois and Michigan. The organization serves patients through inpatient care, outpatient clinics, home health services, and virtual care platforms.

1 investor

Osheru is a medical device company that developed the Ziplyft, a sutureless device and technique for eyelid surgery aimed at surgeons and patients. Its approach targets faster recovery and improved outcomes in oculoplastic and ophthalmic procedures.

1 investor